These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38153388)

  • 1. Acute Cerebellar Ataxia and Myoclonus in SARS-CoV-2-Related Encephalopathy Responsive to Immunotherapy: A Case Series.
    Grazzini M; Godani M; Grisanti S; Benedetti L; Lanza G
    Mov Disord Clin Pract; 2023 Feb; 10(2):343-345. PubMed ID: 38153388
    [No Abstract]   [Full Text] [Related]  

  • 2. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.
    Chan JL; Murphy KA; Sarna JR
    J Neurol; 2021 Oct; 268(10):3517-3548. PubMed ID: 33616739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute cerebellar ataxia and myoclonus with or without opsoclonus: a para-infectious syndrome associated with COVID-19.
    Foucard C; San-Galli A; Tarrano C; Chaumont H; Lannuzel A; Roze E
    Eur J Neurol; 2021 Oct; 28(10):3533-3536. PubMed ID: 33492711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical heterogeneity in patients with myoclonus associated to COVID-19.
    Álvarez Bravo G; Sánchez Cirera L; Angerri Nadal M; Ramió I Torrentà L
    Neurol Sci; 2022 Mar; 43(3):1587-1592. PubMed ID: 34988717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.
    Roy D; Ghosh R; Dubey S; Dubey MJ; Benito-León J; Kanti Ray B
    Can J Neurol Sci; 2021 Jan; 48(1):9-24. PubMed ID: 32753076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia-Myoclonus Syndrome in Patients with SARS-CoV-2 Infection.
    Guerra AF; Martinelli I; Rispoli V; Marcacci M; Cavallieri F; Nizzoli S; Valzania F; Ventura P; Meletti S; Pietrangelo A
    Can J Neurol Sci; 2022 Nov; 49(6):824-825. PubMed ID: 34645540
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid-responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) Presenting with Pure Cerebellar Ataxia.
    Termsarasab P; Pitakpatapee Y; Frucht SJ; Srivanitchapoom P
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():585. PubMed ID: 30191089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ataxia, Involuntary Movement and Paroxysmal Motor Abnormality Associated with COVID-19 Infection].
    Takahashi M
    Brain Nerve; 2022 Jul; 74(7):861-866. PubMed ID: 35860932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report.
    Werner J; Reichen I; Huber M; Abela IA; Weller M; Jelcic I
    BMC Infect Dis; 2021 Mar; 21(1):298. PubMed ID: 33761897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.
    Przytuła F; Błądek S; Sławek J
    Neurol Neurochir Pol; 2021; 55(3):310-313. PubMed ID: 34096013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings.
    Delorme C; Paccoud O; Kas A; Hesters A; Bombois S; Shambrook P; Boullet A; Doukhi D; Le Guennec L; Godefroy N; Maatoug R; Fossati P; Millet B; Navarro V; Bruneteau G; Demeret S; Pourcher V;
    Eur J Neurol; 2020 Dec; 27(12):2651-2657. PubMed ID: 32881133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoclonus and Cerebellar Ataxia Associated with SARS-CoV-2 Infection: Case Report and Review of the Literature.
    Giannantoni NM; Rigamonti E; Rampolli FI; Grazioli-Gauthier L; Allali G; Vanini G
    Eur J Case Rep Intern Med; 2021; 8(5):002531. PubMed ID: 34123943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia Myoclonus Syndrome in Mild Acute COVID-19 Infection.
    Rodriguez-Quiroga S; Aldecoa M; Morera N; Gatti C; Gil C; Garretto N; Fasano A
    Cerebellum; 2023 Oct; 22(5):1026-1028. PubMed ID: 35976551
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome.
    Wiegand SE; Mitchell WG; Santoro JD
    Mult Scler Relat Disord; 2021 May; 50():102855. PubMed ID: 33677410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection - a systematic review.
    Hirschfeld AS
    Neurol Neurochir Pol; 2021; 55(6):549-558. PubMed ID: 34637137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
    Urrea-Mendoza E; Okafor K; Ravindran S; Absher J; Chaubal V; Revilla FJ
    Tremor Other Hyperkinet Mov (N Y); 2021 Feb; 11():7. PubMed ID: 33614199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsoclonus--myoclonus in acute cerebellar ataxia.
    Mitra A; Bajaj S
    J Assoc Physicians India; 1987 Dec; 35(12):853-5. PubMed ID: 3449544
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome.
    Desai J; Mitchell WG
    J Child Neurol; 2012 Nov; 27(11):1482-8. PubMed ID: 22805251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.